Medication info
Nexprazole Tablets 40mg (Esomeprazole Magnesium Hydrate)

Nexprazole Tablets 40mg (Esomeprazole Magnesium Hydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Dihydrate›43.38mg / 1 tablet
Manufacturer / importer
Hanwha Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
28 tablets (14 tablets / Alu-Alu X 2)
Approval status
Active

MFDS item code 201600320 · Approved 2016.01.19 · Insurance code 651601950

Summary

Main use
Treatment of acid-related and ulcer diseases (including rebleeding), Helicobacter pylori eradication, and gastrointestinal disorders caused by anti-inflammatory analgesics
Who uses it
Adults · Children
Adult dosage
Swallow this medicine with a liquid such as water; do not chew or crush it. Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Once symptoms have resolved, subsequent symptoms are controlled by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. For patients at high risk of developing gastric or duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs, as-needed administration is not recommended for controlling recurring symptoms. Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials lasting longer than 4 weeks have not been conducted. Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with a dose of 80 ∼ 160 mg daily. Doses above 80 mg daily should be divided into 2 doses. Administer 40 mg once daily for 4 weeks following induction with intravenous treatment to prevent rebleeding due to gastric or duodenal ulcers. No dose adjustment is necessary. Since there is limited experience in patients with severe renal impairment, administer with caution. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, do not exceed 20 mg of this medicine. No dose adjustment is necessary.
Children's dosage
Adolescents aged 12 years and older — Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. Adolescents aged 12 years and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Adolescents aged 12 years and older — Once symptoms have resolved, subsequent symptoms are controlled by administering 20 mg once daily. Children under 12 years of age — There is no experience with the use of this medicine in children under 12 years of age.

Ingredients

Manufacturer
Hanwha Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related and ulcer diseases (including rebleeding), Helicobacter pylori eradication, and gastrointestinal disorders caused by anti-inflammatory analgesics

  • Gastroesophageal reflux disease
  • erosive reflux esophagitis
  • esophagitis
  • Helicobacter pylori positive duodenal ulcers
  • peptic ulcers
  • upper gastrointestinal pain
  • upper gastrointestinal discomfort
  • upper gastrointestinal burning sensation
  • gastric ulcers
  • duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastric ulcer re-bleeding
View approved original text

This medication is used for the treatment of gastroesophageal reflux disease, especially for the long-term maintenance treatment to prevent recurrence in patients with erosive reflux esophagitis. It is also helpful in relieving symptoms in patients with gastroesophageal reflux disease without esophagitis. It is used in combination with antibiotics for the treatment and prevention of recurrence in patients with Helicobacter pylori positive duodenal ulcers and peptic ulcers. It is effective for the treatment of gastrointestinal symptoms or gastric ulcers resulting from the use of non-steroidal anti-inflammatory drugs, and also for the prevention of gastric and duodenal ulcers. This medication is utilized for the treatment of Zollinger-Ellison syndrome and in maintaining therapy to prevent gastric ulcer or duodenal ulcer re-bleeding. It is used broadly for various gastrointestinal disorders.

Dosage and Administration

Adult dosage

Swallow this medicine with a liquid such as water; do not chew or crush it. Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Once symptoms have resolved, subsequent symptoms are controlled by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. For patients at high risk of developing gastric or duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs, as-needed administration is not recommended for controlling recurring symptoms. Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials lasting longer than 4 weeks have not been conducted. Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with a dose of 80 ∼ 160 mg daily. Doses above 80 mg daily should be divided into 2 doses. Administer 40 mg once daily for 4 weeks following induction with intravenous treatment to prevent rebleeding due to gastric or duodenal ulcers. No dose adjustment is necessary. Since there is limited experience in patients with severe renal impairment, administer with caution. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, do not exceed 20 mg of this medicine. No dose adjustment is necessary.

Children's dosage

Adolescents aged 12 years and older — Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. Adolescents aged 12 years and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Adolescents aged 12 years and older — Once symptoms have resolved, subsequent symptoms are controlled by administering 20 mg once daily. Children under 12 years of age — There is no experience with the use of this medicine in children under 12 years of age.

Precautions

This medication should not be used in patients with known allergies or hypersensitivity to certain ingredients. Additionally, patients who are allergic to penicillin or macrolide antibiotics should be cautious, and it may be dangerous when taken with certain heart medications. Women with a history of heart disease or those who are breastfeeding should also refrain from using this medication. This medication can cause various side effects, with headache, abdominal pain, diarrhea, nausea, and dizziness being frequently reported. Rarely, serious side effects such as blood disorders, hypersensitivity reactions, hypomagnesemia, mental confusion, liver dysfunction, and skin rashes can occur. Regular checks are necessary during long-term use, as the risk of fractures may increase, especially when used for more than one year. There may be a slight increase in the risk of gastrointestinal infections while taking this medication, so patients experiencing persistent diarrhea should consult a doctor. Additionally, it has many drug interactions, so if you are on other medications, you must consult your healthcare provider. The safety of this medication during pregnancy has not been fully established, so it should be used with caution, and breastfeeding should be avoided while taking this medication. In cases of overdose, there are no specific antidotes, so treatment should be symptomatic, and this medication should be kept out of reach of children.

Side effects

leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, confusion, depression, aggression, hallucinations, headache, dizziness, sensory disturbance, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, Lyell's syndrome, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal bloating, allergic reaction, back pain, chest pain, sternal pain, facial swelling, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, rigidity, tachycardia, flushing, hypertension, thyroid gland enlargement, irritable bowel syndrome, exacerbated constipation, dyspepsia, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin levels, tongue disorders, tongue swelling, ulcerative stomatitis, earache, tinnitus, anemia, hypochromic anemia, cervical lymphadenopathy, nosebleed, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, abnormal liver function, elevated ALT, elevated AST, diabetes, hyperuricemia, elevated ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbated arthritis, arthropathy, cramps, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, anorexia, apathy, increased appetite, confusion, worsened depression, hypertonicity, sensory loss, erectile dysfunction, insomnia, migraine, exacerbated migraine, sleep disorders, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, exacerbated asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, altered smell, taste loss, taste distortion, urinary abnormalities, albuminuria, cystitis, difficulty urinating, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyps, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it must be stored in a sealed container. The storage temperature should be kept at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication for a longer period.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

28 tablets (14 tablets / Alu-Alu X 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.